Advertisement
Advertisement
TOPIC

Health in China

Health in China
The latest news, analysis and opinion on Health in China. In-depth analysis, industry insights and expert opinion.
Alibaba

Alibaba open-sources AI model that can detect cancer and nearly 150 conditions

Tested on nearly 40,000 real-world exams, the model outperformed most radiologists, according to a new study published in Science.

Ancient China scholars drank ink for poetic inspiration or poor handwriting penalties

Forget low-calorie food, China youth turn to tasteless, chewy snacks to lose weight

One individual even admits to chewing on dog chew sticks to help alleviate severe exam anxiety.

Why is surrogacy in China proving so difficult to ban despite the crackdown?

Undercover investigation leads to allegations of two labs operating illegally, despite the nation’s tough stance against the practice.

videocam
Advertisement
Advertisement
Advertisement

Overseas licensing has helped fuel China’s biotech profits. Will it last?

Out-licensing deals have overtaken IPOs as the primary lifeline for cash-starved Chinese drug makers, analysts say.

videocam
Asset id: 2156561481

Cross-border out-licensing deals are proving profitable for Chinese drugmakers. Photo: Shutterstock Images
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement